AESTUSRX Trademark

Trademark Overview

On Monday, January 29, 2007, a trademark application was filed for AESTUSRX with the United States Patent and Trademark Office. The USPTO has given the AESTUSRX trademark a serial number of 77093637. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 16, 2015. This trademark is owned by Aestus Therapeutics Inc. The AESTUSRX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
aestusrx

General Information

Serial Number77093637
Word MarkAESTUSRX
Filing DateMonday, January 29, 2007
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 16, 2015
Registration Number3587710
Registration DateTuesday, March 10, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 31, 2007

Trademark Statements

Goods and ServicesPharmaceutical research and development
Pseudo MarkAESTUS RX

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 16, 2015
Primary Code042
First Use Anywhere DateFriday, November 18, 2005
First Use In Commerce DateWednesday, March 1, 2006

Trademark Owner History

Party NameAestus Therapeutics Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNorth Brunswick, NJ 08902
Party NameAestus Therapeutics Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Brunswick, NJ 08902
Party NameAestus Therapeutics Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Brunswick, NJ 08902

Trademark Events

Event DateEvent Description
Friday, October 16, 2015CANCELLED SEC. 8 (6-YR)
Tuesday, March 10, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, February 3, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, February 2, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, January 30, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 30, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 30, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 30, 2009PETITION TO REVIVE-GRANTED
Friday, January 30, 2009TEAS PETITION TO REVIVE RECEIVED
Monday, December 1, 2008ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, December 1, 2008ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, May 1, 2008NON-FINAL ACTION MAILED
Thursday, May 1, 2008SU - NON-FINAL ACTION - WRITTEN
Wednesday, April 30, 2008STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 30, 2008EXTENSION 1 GRANTED
Wednesday, April 9, 2008USE AMENDMENT FILED
Wednesday, April 9, 2008EXTENSION 1 FILED
Wednesday, April 9, 2008TEAS EXTENSION RECEIVED
Wednesday, April 9, 2008TEAS STATEMENT OF USE RECEIVED
Tuesday, October 23, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 10, 2007ASSIGNED TO EXAMINER
Tuesday, July 31, 2007PUBLISHED FOR OPPOSITION
Wednesday, July 11, 2007NOTICE OF PUBLICATION
Tuesday, June 26, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 26, 2007ASSIGNED TO LIE
Thursday, May 24, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 16, 2007ASSIGNED TO EXAMINER
Thursday, February 1, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

aestusrx development research pharmaceutical